Stomach ultrasound may guide safer anesthesia for opioid users

NCT ID NCT07537582

Not yet recruiting Knowledge-focused Sponsor: Danat Al Emarat Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether using a stomach ultrasound before sedation can help anesthesiologists make safer decisions for chronic pain patients. These patients often take opioids or have other conditions that slow stomach emptying, raising the risk of food or liquid entering the lungs during sedation. The study will track how often the ultrasound changes the planned anesthesia approach.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could show that gastric ultrasound helps anesthesiologists make safer decisions for chronic pain patients, potentially reducing rare but serious complications.
What could go wrong: This is an observational study, not a treatment trial. It only measures whether ultrasound changes decisions, not whether it actually prevents harm. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE OPIOID ADMINISTRATION WITHIN 24 HOURS PRIOR TO THE PROCEDURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic pain syndrome diabetes mellitus gastroesophageal reflux disease opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE OPIOID ADMINISTRATION WITHIN 24 HOURS PRIOR TO THE PROCEDURE ASA PHYSICAL STATUS II-III CHRONIC OPIOID USE (≥2 WEEKS) DIABETES MELLITUS WITHOUT ESTABLISHED AUTONOMIC NEUROPATHY GASTRIC ULTRASOUND GASTRIC ULTRASOUND IN ACUTE OPIOID ADMINISTRATION WITHIN 24 HOURS PRIOR TO THE PROCEDURE GASTRIC ULTRASOUND IN CHRONIC OPIOID USE (≥2 WEEKS) GASTRIC ULTRASOUND IN DIABETES MELLITUS WITHOUT ESTABLISHED AUTONOMIC NEUROPATHY GASTRIC ULTRASOUND IN PATIENT WITH SYMPTOMS OF GASTROESOPHAGEAL REFLUX GASTRIC ULTRASOUND IN PATIENTS WITH REDUCED FUNCTIONAL MOBILITY GASTRIC ULTRASOUND IN POORLY CONTROLLED ACUTE-ON-CHRONIC PAIN POORLY CONTROLLED ACUTE-ON-CHRONIC PAIN REDUCED FUNCTIONAL MOBILITY SYMPTOMS OF GASTROESOPHAGEAL REFLUX

Contacts and locations

Locations

Danat Al Emarat Women & Children Hospital

Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates

More trials for these conditions

Other studies related to the condition(s) this trial covers.